bisoprolol + nebivolol

Bisoprolol + nebivolol refers to the combination or comparison of two distinct cardioselective beta-1 adrenergic receptor antagonists. Bisoprolol is a potent, highly selective beta-1 blocker without intrinsic sympathomimetic activity, primarily used for the management of hypertension and chronic heart failure. Nebivolol is a unique third-generation beta-1 selective blocker that also induces vasodilation through the L-arginine/nitric oxide pathway, mediated by beta-3 adrenergic receptor agonism. While both agents are approved for cardiovascular conditions, they are not typically formulated as a fixed-dose combination due to their overlapping pharmacological class. Clinical research, such as studies conducted by the Clinical Hospital Center Zemun, often focuses on head-to-head comparisons of these drugs to evaluate their respective impacts on echocardiographic parameters, hemodynamics, and endothelial function.

Brand names

ZebetaConcorNebiletMonocor

Other names

bisoprolol fumaratenebivolol hydrochloride